Breaking News
Get 40% Off 0
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list
Close

Oncolytics Biotech Inc (ONC)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
1.43 -0.01    -0.69%
18/04 - Closed. Currency in CAD ( Disclaimer )
  • Volume: 23,151
  • Bid/Ask: 1.42 / 1.44
  • Day's Range: 1.41 - 1.45
Type:  Equity
Market:  Canada
Oncolytics Biotech 1.43 -0.01 -0.69%

Oncolytics Biotech Inc Company Profile

 
Get an in-depth profile of Oncolytics Biotech Inc, including a general overview of the company's business and key management, as well as employee data and location and contact information.
IndustryBiotechnology & Medical Research
SectorHealthcare
Employees

-

Equity Type

ORD

Oncolytics Biotech Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of pharmaceutical products for the treatment of cancer. The company is developing pelareorep, an intravenously delivered immunotherapeutic agent, which is in phase 3 clinical trial for the treatment of hormone receptor-positive / human epidermal growth factor 2-negative metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma. It has a co-development agreement with Merck KGaA and Pfizer Inc. to co-develop pelareorep, as well as with Roche Holding AG. The company was incorporated in 1998 and is headquartered in Calgary, Canada.

Contact Information

Address 322 11th Avenue SW Suite 804
Calgary, T2R 0C5
Canada
Phone 403 670 7377
Fax -

Top Executives

Name Age Since Title
Matthew C. Coffey - 1999 President, CEO & Director
Wayne F. Pisano 68 2013 Independent Chairman of the Board
Deborah M. Brown - 2017 Independent Director
Angela Frances Holtham 72 2014 Independent Director
Jean-Pierre Bizzari 69 - Member of Scientific Advisory Board
Bernd Robert Seizinger 68 2015 Independent Director
Aleix Prat - - Member of Scientific Advisory Board
Padmanee Sharma - - Member of Scientific Advisory Board
Martine Piccart - 2017 Member of Scientific Advisory Board
James T. Parsons 59 2022 Independent Director
Richard Vile - 2020 Member of Scientific Advisory Board
Jonathan M. N. Rigby 56 2022 Independent Director
Patricia S. Andrews 65 2024 Independent Director
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

ONC Comments

Write your thoughts about Oncolytics Biotech Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Dina Gene
Dina Gene May 26, 2023 8:18
Saved. See Saved Items.
This comment has already been saved in your Saved Items
go ONC go!!! BRACELET-1 PH2 showing great results!
Garbage Bear
Garbage Bear Nov 23, 2020 14:31
Saved. See Saved Items.
This comment has already been saved in your Saved Items
I wonder how much of this increase is due to their positive clinical results compared to stock market vaccine news.?
Michael Verkerke
Michael Verkerke Mar 24, 2020 14:57
Saved. See Saved Items.
This comment has already been saved in your Saved Items
There's more good news coming down the pipe before months end.
Bachir Nahed
Bachir Nahed Feb 20, 2020 10:02
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Fuck that shit the worse stock ever
Michael Verkerke
Michael Verkerke Feb 20, 2020 10:02
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Told ya it'd spike.
Michael Verkerke
Michael Verkerke Jan 20, 2020 15:35
Saved. See Saved Items.
This comment has already been saved in your Saved Items
She's gonna spike up any day here soon.
Dbankerphfive Dbankerphfive
Dbankerphfive Dbankerphfive Dec 30, 2019 16:01
Saved. See Saved Items.
This comment has already been saved in your Saved Items
I sold 62 shares got my capital back. Let’s hope this will continue.
albert jornacion
albert jornacion Dec 30, 2019 13:03
Saved. See Saved Items.
This comment has already been saved in your Saved Items
should hv bought more than 100 shares
Shane beggs
Shane beggs Dec 27, 2019 12:30
Saved. See Saved Items.
This comment has already been saved in your Saved Items
maybe more buyers than sellers
Dbankerphfive Dbankerphfive
Dbankerphfive Dbankerphfive Dec 27, 2019 12:30
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Why are they buying?
Joe Juresic
Joe Juresic Dec 27, 2019 12:30
Saved. See Saved Items.
This comment has already been saved in your Saved Items
biopharm, medicals seem to be the safe bet as they are a necessity for future... this one deals with cancers etc
Dbankerphfive Dbankerphfive
Dbankerphfive Dbankerphfive Dec 26, 2019 11:47
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Anyone can tell why it’s gaining?
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email